← Evidence map

ArticlePloS one2021

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.

Paul Jank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34469495